to page content
to site navigation
The Foundation's primary site.
Global news, events, and resources.
The national learning program for entrepreneurs.
A new approach to developing the next generation of high-growth firms.
Access to university research and innovation.
The Kauffman Foundation's charter school serving Kansas City.
Encouraging the aspirations of young people.
The platform for business plan competitions.
College preparation and access for urban youth in Kansas City.
A guide to Kauffman Foundation and partner resources, for aspiring entrepreneurs.
News and announcements from the Foundation.
From our vice president of Entrepreneurship.
From our vice president of Advancing Innovation.
News from Global Entrepreneurship Week
News about this education program for entrepreneurs.
Tweets for the eMed Community at Entrepreneurship.org
News from the Kauffman Labs program.
From our business plan competition service.
Contribute to the community seeking to improve entrepreneurship and innovation measurement.
A look at entrepreneurship from the Kauffman Foundation's Thom Ruhe.
Tracks research and policies that are accelerating economic growth and changing the world.
Brings to light various policies and initiatives to advance innovation and drive economic growth.
A selection of our videos
Take our video and audio with you.
Explore many of our publications.
Join the discussion on our LinkedIn site.
Join us on Google's social service.
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
Are bioresorbable stents from one company better than another? Arterial Remodeling Technologies thinks so. The company boasts that its stents offer faster and smoother bioresorption and crack-free expansion.
At this week's Biotech 2011 conference, speakers from Teva Pharmaceutical Industries and Merck spoke about how biotech companies can survive in this tough regulatory and economic environment.
Biotech companies can expect to encounter a few ethical dilemmas with clinical trials and marketing. Read about ethical issues in drug development.
The FDA needs a chief innovation officer to help the agency stay informed about the latest technological advances, says the head of the biotechnology industry's leading trade group. Read more about what he has to say on the FDA and FDA reform.
Biotech companies will have a new resource in the Ohio University Innovation Center’s new biotech research and development facility. Read more to learn about what it will offer.
Communicating before groups can be key to an entrepreneur's success, whether they be employees, customers, or potential investors. Following these eight, quick-read tips will boost your odds of "wowing" your audience.
One sentence was all it took. It came down to a quick choice, and the one he chose probably wrecked his career.
Startup America Partnership CEO Scott Case was asked about women entrepreneurs’ lack of access to venture capital. Case said one challenge facing both women and minority entrepreneurs is “they’re not visible to us.” As a result, Faye Anderson launches "The Innovators" website.
Feld shares some straightforward thoughts on why positions of CEO and board chairman should be separated. This idea has distinct benefits, especially for smaller companies, Feld writes. The piece is one in a series on boards of directors.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.
© 2013 Ewing Marion Kauffman Foundation. All Rights Reserved.